A Randomized Controlled Trial of Long-Term (R)-α-Lipoic Acid Supplementation Promotes Weight Loss in Overweight or Obese Adults without Altering Baseline Elevated Plasma Triglyceride Concentrations
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Background α-Lipoic acid (LA) is a dietary supplement for maintaining energy balance, but well-controlled clinical trials in otherwise healthy, overweight adults using LA supplementation are lacking.Objectives The primary objective was to evaluate whether LA supplementation decreases elevated plasma triglycerides in overweight or obese adults. Secondary aims examined if LA promotes weight loss and improves oxidative stress and inflammation.Methods Overweight adults [n = 81; 57% women; 21-60 y old; BMI (in kg/m2) ≥ 25] with elevated plasma triglycerides ≥100 mg/dL were enrolled in a 24-wk, randomized, double-blind, controlled trial, assigned to either (R)-α-lipoic acid (R-LA; 600 mg/d) or matching placebo, and advised not to change their diet or physical activity. Linear models were used to evaluate treatment effects from baseline for primary and secondary endpoints.Results R-LA did not decrease triglyceride concentrations, but individuals on R-LA had a greater reduction in BMI at 24 wk than the placebo group (-0.8; P = 0.04). The effect of R-LA on BMI was correlated to changes in plasma triglycerides (r = +0.50, P = 0.004). Improvement in body weight was greater at 24 wk in R-LA subgroups than in placebo subgroups. Women and obese participants (BMI ≥ 35) showed greater weight loss (-5.0% and -4.8%, respectively; both P < 0.001) and loss of body fat (-9.4% and -8.6%, respectively; both P < 0.005). Antioxidant gene expression in mononuclear cells at 24 wk was greater in the R-LA group (Heme oxygenase 1 [HMOX1] : +22%; P = 0.02) than in placebo. Less urinary F2-isoprostanes (-25%; P = 0.005), blood leukocytes (-10.1%; P = 0.01), blood thrombocytes (-5.1%; P = 0.03), and ICAM-1 (-7.4%; P = 0.04) at 24 wk were also observed in the R-LA group than in placebo.Conclusions Long-term LA supplementation results in BMI loss, greater antioxidant enzyme synthesis, and less potential for inflammation in overweight adults. Improved cellular bioenergetics is also evident in some individuals given R-LA.This trial was registered at clinicaltrials.gov as NCT00765310.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Significant WL has been demonstrated with the use of green coffee, green tea, α-Lipoic Acid, cocoa, and chitosan [102,104,105,106].”
From Nutrition and Physical Activity in Optimizing Weight Loss and Lean Mass Preservation in the Incretin-Based Medications Era: A Narrative Review (2025) · cites this paper as [106]
Citations
Cites
Prevalence of Childhood and Adult Obesity in the United States, 2011-2012
Ogden, C. L., Carroll, M. D., Kit, B. K., & Flegal, K. M. (2014) · JAMA · doi:10.1001/jama.2014.732 · Cited by 8,072
Alpha-lipoic acid as a biological antioxidant
Packer, L., Witt, E. H., & Tritschler, H. J. (1995) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(95)00017-r · Cited by 1,979 · cited 1×
“Cell and molecular studies have shown that LA exerts strong antioxidant and anti-inflammatory effects (1, 12, 13), but few of these effects were noted in our study.”
BackgroundAlpha-lipoic acid as a dietary supplement: Molecular mechanisms and therapeutic potential
Shay, K. P., Moreau, R. F., Smith, E. J., Smith, A. R., & Hagen, T. M. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.07.026 · Cited by 976 · cited 1×
“Although this study only marginally supports previous work that LA improves antioxidant capacity (5), these data must be couched in their proper context.”
ResultSelf-citationLong-term Drug Treatment for Obesity: A Systematic and Clinical Review
Yanovski, S. Z., & Yanovski, J. A. (2014) · JAMA · doi:10.1001/jama.2013.281361 · Cited by 876 · cited 1×
“Currently approved drugs for long-term weight loss cause 35%–73% of adults who are overweight or obese to lose a clinically meaningful (≥5%) amount of body mass (27).”
BackgroundCawthorn, W. P., & Sethi, J. K. (2008) · FEBS Letters · doi:10.1016/j.febslet.2007.11.051 · Cited by 791 · cited 1×
“Changes in circulating TNFA are not surprising because it is an adipokine at the nexus of triglyceride production and insulin signaling (29).”
BackgroundOral Treatment With α-Lipoic Acid Improves Symptomatic Diabetic Polyneuropathy
Ziegler, D., Ametov, A., Barinov, A., Dyck, P. J., Gurieva, I., Low, P. A., Munzel, U., Yakhno, N., Raz, I., Novosadova, M., et al. (2006) · Diabetes Care · doi:10.2337/dc06-1216 · Cited by 562
Kim, M.-S., Park, J.-Y., Namkoong, C., Jang, P.-G., Ryu, J.-W., Song, H.-S., Yun, J.-Y., Namgoong, I.-S., Ha, J., Park, I.-S., et al. (2004) · Nature Medicine · doi:10.1038/nm1061 · Cited by 522
High-performance liquid chromatography of thiols and disulfides: Dinitrophenol derivatives
Fariss, M. W., & Reed, D. J. (1987) · Methods in Enzymology · doi:10.1016/0076-6879(87)43018-8 · Cited by 503 · cited 1×
“To determine intracellular glutathione and glutathione disulfide concentrations, we adapted the method of Fariss and Reed (21).”
MethodLipoic Acid as a Potential Therapy for Chronic Diseases Associated with Oxidative Stress
Smith, A. R., Shenvi, S. V., Widlansky, M., Suh, J. H., & Hagen, T. M. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043365387 · Cited by 461
Self-citationZHANG, W.-J., & FREI, B. (2001) · The FASEB Journal · doi:10.1096/fj.01-0260com · Cited by 300
Self-citation
Cited by
Fogacci, F., Rizzo, M., Krogager, C., Kennedy, C., Georges, C. M. G., Knežević, T., Liberopoulos, E. N., Vallée, A., Pérez‐Martínez, P., Wenstedt, E. F. E., et al. (2020) · Antioxidants · doi:10.3390/antiox9101011 · Cited by 86
“Bobe, 2020 [26] United States of America Randomized, double-blind, placebo-controlled, parallel-group, clinical study 24 weeks Sedentary lifestyle BMI ≥ 27 kg/m2 TG ≥ 150 mg/dL FPG < 125 mg/dL 600 mg/day α-lipoic acid 40 38 ± 10 * 12 (39) *”
Nanotechnological Approaches to Enhance the Potential of α-Lipoic Acid for Application in the Clinic
Bellini, C., Mancin, F., Papini, E., & Tavano, R. (2024) · Antioxidants · doi:10.3390/antiox13060706 · Cited by 33
Visioli, F., Ingram, A., Beckman, J. S., Magnusson, K. R., & Hagen, T. M. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.12.008 · Cited by 31
Self-citationRojas-Solé, C., Pinilla-González, V., Lillo‐Moya, J., González-Fernández, T., Saso, L., & Rodrigo, R. (2023) · Redox Report · doi:10.1080/13510002.2023.2289740 · Cited by 24
Gonzalez, D. E., Dickerson, B. L., Roberts, B. M., Kurtz, J. A., Waldman, H. S., Gonzalez, A. M., McAllister, M. J., Heileson, J. L., Bloomer, R. J., Arent, S. M., et al. (2026) · Journal of the International Society of Sports Nutrition · doi:10.1080/15502783.2026.2629828 · Cited by 21
A Multi-Ingredient Supplement Protects against Obesity and Infertility in Western Diet-Fed Mice
Nilsson, M. I., May, L. L., Roik, L. J., Fuda, M. R., Luo, A., Hettinga, B. P., Bujak, A. L., & Tarnopolsky, M. A. (2023) · Nutrients · doi:10.3390/nu15030611 · Cited by 16
“Bobe and colleagues reported that α-LA supplementation reduced body mass index and urinary F2-isoprostanes (marker of lipid peroxidation) in overweight and obese women [80], and recent meta analyses generally confirm a modest but significant weight loss following α-LA supplementation [81–83].”
BackgroundBarana, L., De Fano, M., Cavallo, M., Manco, M., Prete, D., Fanelli, C. G., Porcellati, F., & Pippi, R. (2025) · Nutrients · doi:10.3390/nu18010131 · Cited by 13
“Bobe G. et al. [106] N: 81 Mean age: 39 ± 9 yrs Mean BMI = 34.6 ± 6.1 (kg/m 2 ) 600 mg/d of (R)- α -lipoic acid (R-LA) supplementation vs. placebo Duration: 24 weeks The R-LA group had a greater BMI reduction than the placebo at 24 weeks ( − 0.8; p = 0.04).”
InfluentialSater, Z. A., Cero, C., Pierce, A. E., Lea, H. J., Sater, H. A., ZHU, K. Y., Liu, N., Ma, Y., Gavrilova, O., & Cypess, A. M. (2021) · Obesity · doi:10.1002/oby.23309 · Cited by 15
“It is a potent antioxidant (17) that restores the age- related decline of mitochondrial lipoylation (18), and it also has antiinflammatory activity (19) and may even promote weight loss in adults with overweight (20).”
Watson, P. R., Stollmaier, J. G., & Christianson, D. W. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105228 · Cited by 13
Vajdi, M., Noshadi, N., Hassanizadeh, S., Bonyadian, A., Seyedhosseini-Ghaheh, H., & Askari, G. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1272837 · Cited by 12
Luo, Y., Zhang, J., & Guo, H. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-088363 · Cited by 9
“Nevertheless, we performed Begg’s test and found no evidence of publication bias in our analysis (online supplemental figures S7–S12).”
Multimodal (Bio)Markers and Risk of Obesity – A Comprehensive Scoping Review
Vahid, F., Loyola-Leyva, A., Tur, J. A., Bouzas, C., Devaux, Y., Malisoux, L., García-Hernández, S., Carvalho, M. D., Ródenas-Munar, M., Turner, J., et al. (2025) · Advances in Nutrition · doi:10.1016/j.advnut.2025.100579 · Cited by 9
Mohammadi, S., Ashtary‐Larky, D., Alaghemand, N., Alavi, I., Erfanian-Salim, M., Pirayvatlou, P. S., Ettehad, Y., Borzabadi, A., Mehrbod, M., & Asbaghi, O. (2025) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2025.104370 · Cited by 5
R-α-Lipoic Acid and 4-Phenylbutyric Acid Have Distinct Hypolipidemic Mechanisms in Hepatic Cells
He, B., & Moreau, R. F. (2020) · Biomedicines · doi:10.3390/biomedicines8080289 · Cited by 5
Coenzyme Q10 and Obesity: An Overview
Mantle, D., Kozhevnikova, S., & Larsen, S. (2025) · Antioxidants · doi:10.3390/antiox14070871 · Cited by 5
“Thus, supplementation with alpha lipoic acid (600 mg/day for 24 weeks) resulted in weight loss and improved oxidative stress and inflammation [103].”
Đukić, L., Trajković, L., Knežević, T., Dimitrijević, J., Krstic, D. Z., & Stojanović, M. (2022) · Dose-Response · doi:10.1177/15593258221126827 · Cited by 3
Exploring the Pharmacotherapeutic Potential of Natural Compound Alpha Lipoic Acid
Udaipurwala, A., Pimple, P. M., & Sawarkar, S. P. (2025) · The Natural Products Journal · doi:10.2174/0122103155309474240826105734 · Cited by 2
α-Lipoic acid as an ingredient of specialized food product and dietary supplement
Kodentsova, V. M., & Risnik, D. V. (2023) · Medical alphabet · doi:10.33667/2078-5631-2023-29-48-54 · Cited by 2
Welyczko, N. (2020) · Gastrointestinal Nursing · doi:10.12968/gasn.2020.18.8.10
Welyczko, N. (2020) · Gastrointestinal Nursing · doi:10.12968/gasn.2020.18.10.10
Sooklert, K., Thamakaison, S., Nilyai, S., Cherdchom, S., Rojanathanes, R., & Sereemaspun, A. (2024) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2024.101402
Netsuksang, P., Bunnag, S., Thetsana, P., & Teng-umnuay, P. (2025) · Proceedings of the International Conference on Food, Nutrition, Health and Lifestyle · doi:10.17501/24246778.2024.3101
Thompson, T., Tanwar, V., Hoskinson, W., Peterson, K. R., SOTHERN, M. S., McKibbin, C. L., Missikpode, C., Kapahi, P., & Dhar, S. (2025) · medRxiv · doi:10.1101/2025.09.04.25335119
“13,17,26,27 Yet, presently there are no clinical studies evaluating the rigorously-tested combination of glycation lowering GRAS (Generally Regarded As Safe) ingredients, which are needed to validate promising preclinical findings.”
The role of lipoic acid in weight management and physical performance
Πανταζέλου, Δ. Κ., & Χότζα, Ν. Γ. (2025) · University of Thessaly Institutional Repository (University of Thessaly)
Metadata
- Authors
- Bobe, G., Michels, A. J., Zhang, W.-J., Purnell, J. Q., Woffendin, C., Pereira, C., Vita, J. A., Thomas, N. O., Traber, M. G., Frei, B., & Hagen, T. M.
- Affiliations
- Oregon State University (US)
- Oregon Health & Science University (US)
- Boston University (US)
- Corresponding author
- Hagen, Tory M
- ORCID
- Venue
- The Journal of Nutrition
- Publisher
- Elsevier BV
- Published
- 2020-09
- Volume
- 150
- Issue
- 9
- Pages
- 2336-2345
- ISSN
- 0022-3166 (ISSN-L)
- PMC
- PMC7540064
- OpenAlex
- W3043941737
- Cited by
- 22
- References
- 29
- Citations by year
- 2026: 1 · 2025: 7 · 2024: 2 · 2023: 5 · 2022: 1 · 2021: 2 · 2020: 4
- FWCI
- 1.28
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 868 d)
- Locations
- Journal of Nutrition (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Center for Complementary and Alternative Medicine (P01 AT002034)
- NIH
- National Center for Advancing Translational Sciences (UL1TR000128)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Biochemical Acid Research Studies
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Keywords
- R-alpha-lipoic acid, dietary supplementation, weight loss, obesity, overweight, plasma triglycerides, oxidative stress, inflammation, heme oxygenase-1, F2-isoprostanes, ICAM-1, leukocyte activation, fat loss, sex differences, energy balance, mononuclear cells, leukocyte telomere length
- MeSH terms
- Adult, Drug Administration Schedule, Female, Humans, Thioctic Acid, Male, Middle Aged, Triglycerides, Weight Loss, Exercise, Dietary Supplements, Overweight, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.